Declaration of patent applications as financial interests: A survey of practice among authors of papers on molecular biology in Nature

Journal of Medical Ethics

Volumn 32, Issue 11, 2006, Pages 658-661

  Mayer, Sue ^a  

^a GeneWatch UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOTECHNOLOGY; INTERNET; INTERPERSONAL COMMUNICATION; MALPRACTICE; MEDICAL RESEARCH; MOLECULAR BIOLOGY; MOLECULAR GENETICS; PATENT; PUBLICATION; PUBLISHING; REGISTER; RESEARCH ETHICS; SCIENTIFIC MISCONDUCT;

BIOTECHNOLOGY; CONFLICT OF INTEREST; DISCLOSURE; FINANCIAL SUPPORT; GENETIC RESEARCH; GENETICS; HUMANS; MOLECULAR BIOLOGY; PATENTS; PERIODICALS;

EID: 33751215107     PISSN: 03066800     EISSN: None     Source Type: Journal    
DOI: 10.1136/jme.2005.014290     Document Type: Article

References (27)

1. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. 2004. http://www.icmje.org (accessed 5 Sep 2005).
2. Krimsky S. Science in the private interest. Has the lure of profits corrupted biomedical research? Lanham, MD: Rowman and Littlefield, 2003:57-71.
3. Kong JX, Wong J, Wu L, et al. Fat-1 mice convert n-6 to n-3 fatty acids. Nature 2004;427:504.
4. GeneWatch UK. GM animals high in omega-3 fatty acids: scientist ready to cash in via patent. GeneWatch UK response to paper published in Nature today. Press release, 5 Feb 2003. http://www.genewatch.org/ Press%20Releases/pr58.htm (accessed 2 Jun 2006).
5. Anon. Corrigendum. Nature 20014;427:698.
6. Falck J, Coates J, Jackson SP. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 2005;434:605-11.
7. Farmer H, McCabe N, Lord CJ, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005;434:917-21.
8. Urnov FD, Miller JC, Lee Y-L, et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 2005;435:646-51,
9. Gu K, Yang B, Tian D, et al. R gene expression induced by a type-III effector triggers disease resistance in rice. Nature 2005;435:1122-5.
10. Mueller A-K, Labaied M, Kappe SH-I, et al. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 2005,433:164-76.
11. Laugwitz K-L, Moretti A, Lam J, et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005;433:647-53.
12. Mueller KL, Hoon MA, Erlenbach I, et al. The receptors and coding logic for bitter taste. Nature 2005;434:225-9.
13. Glasson SS, Askew R, Sheppard B, et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005;434:644-8.
14. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005;434:843-50.
15. Bryant HE, Schultz N, Thomas HD, et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 2005;434:913-7.
16. Lawrence T, Bebien M, Liu GY, et al. IKK limits mocrophage NF-β activation and contributes to the resolution of inflammation. Nature 2005;434:1138-43.
17. Menard R. Knockout malaria vaccine? Nature 2005;433:113-4.
18. Shanahan M. GM malaria parasite could lead to vaccine'. SciDev.Net, 7 Dec 2004. http://www.scidev.net/News/ index.cfm?fuseaction=readnews&itemid=1787&lanquage=1 (accessed 2 Jun 2006).
19. Mummery CL. Solace for the broken hearted? Nature 2005;433:585-6.
20. University of California. UCSD team discovers specialised, rare heart stem cells in new borns. Eurekalert 9 Feb 2005. http://www.eurekcilert.org/pub_releases/2005-02/uoc-utd020205.php (accessed 5 Sep 2005).
21. Venitikaraman AR. Medicine: aborting the birth of cancer? Nature 2005;434:829-30.
22. Swedish Research Council. New treatment for hereditary breast cancer. EurekAlert 14 Apr, 2005 http://www.eurekalert.org/press_releases/2005-04/ src-atf041405.pnp (accessed 5 September 2005).
23. Bartkova J, Hor Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005;434:864-70.
24. Fontanarosa P, Flanagin A, DeAngelis CD. Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. JAMA 2005;294:110-1.
25. Bekelman JE, Li Y, Gross CP. Scope and impact of financial interest in biomedical research. A systematic review. JAMA 2003;289:454-65.
26. Goozner M. Unrevealed: non-disclosure of conflicts of interest in four leading medical and scientific journals. Washington, DC: Center for Science in the Public Interest, 2004.
27. van Kolfschooten F. Can you believe what you read? Nature 2002;416:360-3.